J. Marques

Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper

T. Marques, V. Hespanhol, F. Barata, 2021, Drug Safety.

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

M. J. van den Bent, M. Taphoorn, O. Chinot, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.